K

Search

All10000+Clinical Trials10000+Companies44Drugs1415News1833

TMEM16 modulators (Covid 19/flavi virus infection)

hemagglutinin-neuramidase inhibitor (human parainfluenza virus infection)

GPR183 modulators (osteoporosis/Epstein-Barr virus infection)

T-cell receptor mimic mAbs (TCRm, infection)

VLP vaccine (ADDomer, coronovirus disease 19 infection)

CAR-NK cell therapy (COVID-19 infection)

virus protease inhibitor (oral, Zika virus infection)

4’-phosphopantetheinyl transferase inhibitors (mycobacterium tuberculosis infection)

mRNA based prophylactic vaccines (urinary tract infection)

RSV AI program (respiratory syncytial virus infection)

mRNA vaccine LNP (intramuscular, influenza virus infection)

HIV-1 Vif inhibitors (HIV-1 infection)

anti-NDM-1 therapy (cancer/ bacterial infection)

mRNA NA vaccine (intramuscular, influenza virus infection)

human IgG1 monoclonal antibody (hepatitis B infection)

anti-CSP monoclonal antibody (Plasmodium falciparum infection)

Recombinant RSV vaccine (PIV5-vectored; RSV infection)

multi-targeting drug conjugate (Helicobacter pylori infection)

PAPD5 inhibitor (dyskeratosis congenita, hepatitis B infection)

DapE targeting metalloenzyme inhibitors (Haemophilus influenza infection)

• Prev
• 1
• 51
• 52
• 53
• 54
• 55
• 71
• Next